Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: March 26, 2025 to April 1, 2025
Business Overview: CCEP is a leading consumer goods company operating in 31 countries, serving nearly 600 million consumers and over 4 million customers. The company is listed on Euronext Amsterdam, NASDAQ (Nasdaq 100 constituent), London Stock Exchange, and Spanish Stock Exchanges.
Key Financial Metrics and Transactions
This filing details specific share repurchase transactions under an ongoing buyback programme. It does not contain consolidated revenue, profit, cash flow, or debt metrics for the period.
| Date of Purchase | Venue | Shares Purchased | Price Range (High/Low) | VWAP |
|---|---|---|---|---|
| March 25, 2025 | US Trading Venues | 39,077 | USD 84.63 / 83.81 | USD 84.09 |
| March 26, 2025 | US Trading Venues | 62,414 | USD 85.36 / 83.76 | USD 84.70 |
| March 27, 2025 | US Trading Venues | 65,125 | USD 86.39 / 85.40 | USD 85.99 |
| March 28, 2025 | US Trading Venues | 64,617 | USD 87.41 / 85.83 | USD 86.83 |
| March 31, 2025 | US Trading Venues | 35,309 | USD 87.40 / 86.40 | USD 87.09 |
| March 31, 2025 | London Trading Venues | 18,417 | GBP 67.80 / 66.80 | GBP 67.14 - 67.28 |
Total Shares Repurchased in Period: 284,959 ordinary shares.
All repurchased shares are cancelled. The total programme authorisation is up to EUR 1 billion.
Material Changes and Programme Updates
Buyback Programme Adjustment: On March 28, 2025, the Company announced a reallocation within the initial tranche of the buyback programme (totaling EUR 275 million, expected completion by May 23, 2025).
- Previous Allocation: EUR 55 million for London Trading Venues.
- New Allocation: Increased to EUR 67 million for London Trading Venues.
- Completion Date: London Trading Venues purchases are expected to be completed by May 16, 2025.
Trading Activity: Prior to March 31, all purchases were executed on US Trading Venues. On March 31, the Company resumed purchases on London Trading Venues (London Stock Exchange, CBOE Europe, Aquis) alongside US venues.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the Company is actively executing its capital return strategy through share cancellations. No specific operational guidance or earnings outlook is provided in this document.
Risks and Contingencies: The filing states that the announcements do not constitute an offer or solicitation of securities. Transactions are conducted in compliance with the Market Abuse Regulation (EU) No 596/2014 as applied in the UK.
Investor Verification Checklist
- Programme Progress: Verify the cumulative amount spent against the EUR 1 billion total authorisation and the EUR 275 million initial tranche.
- Share Count Impact: Confirm the reduction in total outstanding shares following the cancellation of 284,959 shares in this period.
- London Venue Execution: Monitor the execution of the increased EUR 67 million allocation for London Trading Venues against the May 16, 2025 deadline.
- Price Trends: Note the upward trend in share prices during the period (USD 83.81 to 87.41 on US venues; GBP 66.80 to 67.80 on London venues).